2.Clinical Effects of E. cole Derived Authentic REcombinant Human Growth Hormone(DA-3002) in Children with Growth Hormone Deficiency.
Se Won YANG ; Byung Chul LEE ; Chul Woo KO ; Duk Hee KIM ; Han Wook YOO ; Woo Young CHUNG
Journal of Korean Society of Endocrinology 1998;13(4):526-535
BACKGROUND: Recently authentic human growth hormone(hGH) has produced in the E coli K-12, W3110 by recombinant DNA tecbnology in Korea In this paper, the clinical efficacy and immunogenicity of this GH was shdied in 38 children with growth hormone deficiency during therapy of 1 year. METHODS: The subjects of this study were aged 4.9-13.9 years, diagnosed by failure of plasma GH to respond to insulin-induced hypoglycemia, arginine and/or L-dopa loading and height below -2 standard deviation of mean for their chronological age. Each patient received GH 0.5-0.7IU/kg/week subcutaneously in 6-7 divided doses. During treatment, vital signs, height, body weight and bone age were checked every 3 months. Complete blood count, urinalysis, blood chemistry and thyroid hormone were checked before and every 6 months. The measurement of serum IGF-1 level and antibody against hGH were performed before and every 6 months during therapy of I year. RESULT: The height velocities significantly increased from 3.3 +/- 1.5cm/year to 10.1 +/- 2.5 and 9.0 +/- 1.8cm/year at 6 and 12 months of therapy, respectively. The height standard deviation score for chronological age were significantly improved from -2.141.50 to -1.74 +/- 1.43 and -1.54 +/- 1.38 at 6 and 12 months of therapy with increasing ratio of bone age to chronological age from 0.72 +/- 0.15 at pretreatment to 0.76 +/- 0.15 at 6 month, 0.79 +/- 0.16 at 12 month of therapy. The plasma IGF-1 level significantly increased during treatment. One of 36 patients(2.8%) showed positive antibody against hGH after 1 year of treatment. During therapy of 1 year, unwanted and remarkable clinical side effect were not observed in all subjects. CONCLUSION: These results indicate that this E. coli derived authentic recombinant growth hormone is very effective in stimulating linear growth in children with growth hormone deficiency.
Arginine
;
Blood Cell Count
;
Body Height
;
Chemistry
;
Child*
;
DNA, Recombinant
;
Escherichia coli
;
Growth Hormone*
;
Human Growth Hormone
;
Humans*
;
Hypoglycemia
;
Insulin-Like Growth Factor I
;
Korea
;
Levodopa
;
Plasma
;
Thyroid Gland
;
Urinalysis
;
Vital Signs
3.Flexor hallucis Longus Tendinitis in Classical Ballet Dancer.
Kyung Tai LEE ; Joon Woo BAE ; Han Chul KIM ; Woo Koo CHUNG
The Journal of the Korean Orthopaedic Association 1997;32(2):313-317
Flexor hallucis longus tendinitis is a common overuse syndrome in classic ballet dancers. To describe the clinical symptoms, diagnosis and non-operative and operative treatment, we evaluated twenty ballet dancers from march 1994 to August 1995. For the diagnosis, Tomasen test was helpful clinically and MRI was essential for surgical intervetion to find a tendon degeneration. Patients were classified into three groups by symptoms and clinical stages. All of the Group 1 and 2 were recovered by means of the conservative treatment. Two dancers belongs to Group 3 showed a severe degeneration of tendon on the MRI scan, finally was taken the an operation. Release of the tarsal tunnel were performed. Six months after operation, they could return to dancing.
Cumulative Trauma Disorders
;
Dancing
;
Diagnosis
;
Humans
;
Magnetic Resonance Imaging
;
Tendinopathy*
;
Tendons
4.Immunohistochemical Analysis of Cutaneous Pseudolymphoma.
Kwang Hyun CHO ; Kwang Ho HAN ; Jin Ho CHUNG ; Hee Chul EUN ; Jai Il YOUN ; Chul Woo KIM
Korean Journal of Dermatology 1999;37(2):198-205
BACKGROUND: In the skin, it is often difficult to differentiate lymphomas from reactive lymphoid lesions by light microscopic examination. OBJECTIVE: Our purpose was to determine whether immunologic data obtained from mutine-processed specimens could be used to further objective morphologic interpretations. METHODS: We conducted an immunohistochcmical staining in 44 cases of benign and malignant cutaneous lymphoproliferative lesions using nine antibodies, including anti-CD3, UCHL1, MT1, MT2, L26, MB2, BerH2, 123C3, and MIB1. RESULTS: 1. Immunophenotyping with anti-CD3, UCHL1, MT1, L26, and MB2 was useful for the diagnosis of T cell or B cell lymphoma. However, these antibodies showed a lack of specificity for neoplastic cells, 2. Antibody to CD56, 123C3 showed positivity in 4 cases of angiocentric lymphoma, but negativity in 8 cases showing angiocentric lymphoma-like pathology. 3. Antibody to CD30, BerH2 showed positivity in all 6 cases of CD30 positive large cell lymphoma, but negativity in 6 cases showing diffuse lymphoma-like pathology. 4. Antibody to Ki-67, MIB1 showed positivity in more than 30% of infiltrating cells in 6 cases of angiocentric lymphoma, 4 cases of diffuse B cell lymphoma, and in more than 60% of infiltrating cells in 6 cases of CD30 positive large cell lymphoma. CONCLUSION: These observations suggest that immunostaining may provide useful adjunctive information in distinguishing benign from malignant cutaneous lymphoproliferations in paraffin sections.
Antibodies
;
Diagnosis
;
Immunophenotyping
;
Lymphoma
;
Lymphoma, B-Cell
;
Paraffin
;
Pathology
;
Pseudolymphoma*
;
Sensitivity and Specificity
;
Skin
5.The Value of Immunohistochemistry on Paraffin Embedded Tissue Sections in the Differentiation of Subgroups of Low Grade B-Cell Lymphomas.
Tae Sook HWANG ; Seung Sook LEE ; Ji Eun KIM ; Hye Seung HAN ; Chul Woo KIM
Korean Journal of Pathology 1998;32(12):1066-1073
There had been a continuous evolution of lymphoma classification and recently a Revised European-American Lymphoma Classification was proposed by the International Lymphoma Study Group. This new classification often requires information on immunophenotypic and molecular biologic markers in addition to the usual histologic findings. Recent advances in the production of commercially available monoclonal antibodies reactive on formalin-fixed paraffin-embedded tissues provide us a great help to classify the non-Hodgkin's lymphoma. We have analyzed 31 low grade B-cell lymphomas by the schemes proposed by the International Lymphoma Study Group using antibodies to CD3, CD5, CD20, CD23, CD43, cyclin D1, and bcl-2 protein, and have analyzed the immunophenotypic features. Among 31 low grade B-cell lymphomas, 8 small lymphocytic lymphomas, 5 mantle cell lymphomas, 7 follicle center lymphomas (2 grade I, 3 grade II, and 2 grade III), and 11 marginal zone B-cell lymphomas (all of which were extranodal) were identified. Among 8 small lymphocytic lymphomas, 5 cases were positive for CD5; 6 cases were positive for CD23; 7 cases were positive for CD43; all 8 cases were negative for cyclin D1; and 7 cases were positive for bcl-2. Among 5 mantle cell lymphomas, 4 cases were positive for CD5 and CD43; all five cases were negative for CD23; 4 cases were positive for cyclin D1 and bcl-2. All 7 follicle center lymphomas were negative for CD5, CD43 and cyclin D1 and 2 cases were positive for CD23; and 6 cases were positive for bcl-2. All marginal zone B-cell lymphomas were negative for CD5, CD23 and cyclin D1; 3 cases were positive for CD43 and 9 cases were positive for bcl-2. Diagnostic utility for CD5 antigen detection on paraffin embedded tissue has a limitation due to weak antigen expression in tumor cells of B-cell lymphomas; however, still be useful in differentiating small lymphocytic lymphoma and mantle cell lymphoma from other B-cell lymphomas when applied in conjunction with CD43. CD23, CD43, and cyclin D1 appear to be of great help in differentiating subgroups of low grade B-cell lymphomas. Bcl-2, as known, is found to be useful to rule out reactive follicular hyperplasia.
Antibodies
;
Antibodies, Monoclonal
;
Antigens, CD5
;
B-Lymphocytes*
;
Biomarkers
;
Classification
;
Cyclin D1
;
Hyperplasia
;
Immunohistochemistry*
;
Leukemia, Lymphocytic, Chronic, B-Cell
;
Lymphoma
;
Lymphoma, B-Cell*
;
Lymphoma, B-Cell, Marginal Zone
;
Lymphoma, Mantle-Cell
;
Lymphoma, Non-Hodgkin
;
Paraffin*
6.A Case of Bx.
Shee Ne KIM ; Woo Seok KIM ; Han Chul SON ; Soon Ho KIM
Korean Journal of Blood Transfusion 1994;5(2):169-172
An ABO discrepancy was observed in a 37-year-old patient with duodenal ulcer bleeding and B subgroup was suspected. The results of adsorption-elution test, saliva and serum inhibition test and family study suggested Bx phenotype that is not a usual phenotype and is the second case to be reported in Korea.
Adult
;
Duodenal Ulcer
;
Hemorrhage
;
Humans
;
Korea
;
Phenotype
;
Saliva
7.A Case of Sepsis and Acute Renal Failure Associated with Salmonella Enterocolitis.
Chul Han KIM ; Ki Tae SUK ; Jae Woo KIM
The Korean Journal of Gastroenterology 2008;52(2):110-114
Salmonella infection can cause an asymptomatic intestinal carrier state or clinical diseases such as enterocolitis presenting abdominal pain, fever, vomiting, or diarrhea. Salmonella usually invades Peyer's patch of terminal ileum or ascending colon. Sepsis is not common and acute renal failure secondary to rhabdomyolysis is rare. The causes of rhabdomyolysis are trauma, excessive exercise, alcohol, seizure, metabolic abnormality, and infection. Infections account for less than 5% of the reported causes of rhabdomyolysis and resulting acute renal failure. The mechanisms underlying rhabdomyolysis due to infection are direct muscle invasion, toxin production, and nonspecific effects that can occur with infections such as fever, dehydration, acidosis, and electrolyte imbalance. We report a case of sepsis and acute renal failure secondary to rhabdomyolysis associated with Salmonella infection.
Colonoscopy
;
Enterocolitis/complications/*diagnosis
;
Humans
;
Kidney Failure, Acute/*diagnosis/etiology
;
Male
;
Middle Aged
;
Rhabdomyolysis/diagnosis/etiology/microbiology
;
Salmonella Infections/complications/*diagnosis
;
Sepsis/*diagnosis/etiology
;
Tomography, X-Ray Computed
8.Primary Primitive Neuroectodermal Tumor of the Kidney.
Woong Kyu HAN ; Won Jae YANG ; Sung Yong CHO ; Seung Chul YANG ; Woo Hee JUNG
Korean Journal of Urology 2000;41(3):456-458
No abstract available.
Kidney*
;
Neuroectodermal Tumors, Primitive*
9.Santonin-kainic acid complex as a mass chemotherapeutic of Ascaris lumbricoides control in Korea.
Soon Hyung LEE ; Se Chul KANG ; Jong Ho AHN ; Jung Woo LEE ; Han Jong RIM
The Korean Journal of Parasitology 1972;10(2):79-85
Santonin-kainic acid complex was evaluated as a chemotherapeutic of the mass treatment of the Ascaris lumbricoides infection in Korea. The results could be summarized as follows: The negative conversion rate was 82.9% in average in 4 treated groups. Some variations of negative conversion rate among the treated groups were noticed. The egg reduciton rate was 97.7% in average and the results were rather uniform among the three evaluated groups. By the analysis of egg reduction, it seems that the lightly infected cases whose E.P.G. were under 5,000 were resistant to treatment with the less reduced egg output. After the treatment with this complex, the number of egg discharged cases were reduced to 1.84% and the average number of discharge eggs per incompletely treated or untreated cases were reduced to 12.5% compared with the level of before-treatment egg output. The successive observations of the pattern of worm expulsion after drug intake was made. The worms were mostly expelled in the stool within 3 days, and 58.9% of total expelled worms were collected within 24-hour stool. The minimum length of the immature worms expelled was 7.6cm. Among the 659 Ascaris collected in the first-day stool from 91 rural people, 8.5% were in the range of 7.6-12.2 cm-long, immature worms. The sex ratio, male: female= 0.69: 1.
parasitology-helminth-nematoda
;
Ascaris lumbricoides
;
chemotherapy
;
Santonin
;
kainic acid
10.Infantile Hypertrophic Pyloric Stenosis Treated with Intravenous Atropine Sulfate.
Jae Woo LIM ; Hee Sook SON ; Kye Shik SHIM ; Kyu Chul CHOEH ; Tae Il HAN
Journal of the Korean Pediatric Society 2000;43(6):763-768
PURPOSE: The pharmacologic effect of atropine on HPS can be considered to control pyloric muscle spasm. Therefore, we studied the effects of intravenous atropine sulfate on the clinical course of HPS, and periodically observed the ultrasonographic appearance of the pyloric muscles after atropine treatment. METHODS:From April 1998 to May 1999, 14 infants who were diagnosed with HPS were treated with intravenous atropine sulfate. Intravenous atropine sulfate was administered at an initial dose of 0.04mg/kg/day, which was divided into 8 equal doses. The daily dose was increased by 0.01 mg/kg/day until vomiting was controlled for an entire day while infants received unrestricted oral feeding. Ultrasonographic examinations were performed during hospitalization and repeated at least every 2 months until normalization of pyloric muscles was confirmed. RESULTS: Intravenous atropine was effective in 12 of 14 infants with HPS and the conditions of 9 of them improved. Two infants who were not free from vomiting despite a week of intravenous atropine sulfate treatment underwent pyloromyotomy. A series of ultrasonographic examinations were done after vomiting had improved with intravenous atropine sulfate. The ultrasonographic findings showed good passage of gastric contents through pyloric canals despite thickening of the pyloric muscles. CONCLUSION: Intravenous administration of atropine sulfate is an effective therapy for HPS and can be an alternative to pyloromyotomy. (J Korean Pediatr Soc 2000;43:763-768)
Administration, Intravenous
;
Atropine*
;
Hospitalization
;
Humans
;
Infant
;
Muscles
;
Pyloric Stenosis, Hypertrophic*
;
Spasm
;
Vomiting